Cargando…

Impact of Clostridioides difficile Therapy on Nosocomial Acquisition of Vancomycin-Resistant Enterococci

Vancomycin is frequently used for the treatment of C. difficile infections (CDI). There are concerns that this might increase the risk of selecting vancomycin resistant enterococci (VRE). Here, we evaluated whether there is an increased risk of VRE acquisition following vancomycin for CDI specific t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correa-Martínez, Carlos L., Hagemeier, Niklas C. J., Froböse, Neele J., Kampmeier, Stefanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625989/ https://www.ncbi.nlm.nih.gov/pubmed/34832848 http://dx.doi.org/10.3390/ph14111066

Ejemplares similares

Transmission of Vancomycin-Resistant Enterococci in the Hospital Setting: Uncovering the Patient–Environment Interplay
por: Correa-Martinez, Carlos L., et al.
Publicado: (2020)

A nosocomial cluster of vancomycin resistant enterococci among COVID-19 patients in an intensive care unit
por: Kampmeier, Stefanie, et al.
Publicado: (2020)

Clostridioides difficile and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
por: Bogdanová, Kateřina, et al.
Publicado: (2021)

Sex differences in vancomycin-resistant enterococci bloodstream infections—a systematic review and meta-analysis
por: Correa-Martínez, Carlos L., et al.
Publicado: (2021)

Weekly screening supports terminating nosocomial transmissions of vancomycin-resistant enterococci on an oncologic ward – a retrospective analysis
por: Kampmeier, Stefanie, et al.
Publicado: (2017)

Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation
por: Correa-Martínez, Carlos L., et al.
Publicado: (2020)

Development and Validation of a Tool for the Prediction of Vancomycin-Resistant Enterococci Colonization Persistence—the PREVENT Score
por: Boeing, Christian, et al.
Publicado: (2021)

Nosocomial Infection with Vancomycin-dependent Enterococci
por: Tambyah, Paul A., et al.
Publicado: (2004)

Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence—A Prospective Longitudinal Study
por: Correa-Martinez, Carlos L., et al.
Publicado: (2019)

Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study
por: Correa-Martínez, Carlos L., et al.
Publicado: (2022)

Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
por: Puchter, Laura, et al.
Publicado: (2018)

Reduced Acquisition and Overgrowth of Vancomycin-Resistant Enterococci and Candida Species in Patients Treated With Fidaxomicin Versus Vancomycin for Clostridium difficile Infection
por: Nerandzic, Michelle M., et al.
Publicado: (2012)

High-level Aminoglycoside Resistance and Reduced Susceptibility to Vancomycin in Nosocomial Enterococci
por: Adhikari, Luna
Publicado: (2010)

The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study
por: Remschmidt, Cornelius, et al.
Publicado: (2017)

Vancomycin-resistant enterococci: eradication using vancomycin?
por: Van Prehn, J, et al.
Publicado: (2014)

Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillance
por: Remschmidt, Cornelius, et al.
Publicado: (2018)

Emergence of vancomycin-resistant enterococci.
por: Rice, L B
Publicado: (2001)

Hospital acquired vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study
por: Kampmeier, Stefanie, et al.
Publicado: (2018)

Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile: A Systematic Review
por: Eubank, Taryn A., et al.
Publicado: (2022)

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
por: Kara, Ahu, et al.
Publicado: (2014)

Impact of the COVID-19 Pandemic on the Management of Staphylococcus aureus Bloodstream Infections in a Tertiary Care Hospital
por: Böing, Christian W., et al.
Publicado: (2023)

Risk Factors for Recurrence of Clostridium difficile Infection: Effect of Vancomycin-resistant Enterococci Colonization
por: Choi, Hee Kyoung, et al.
Publicado: (2011)

Vancomycin-resistant Enterococci, Mexico City
por: Cuellar-Rodríguez, Jennifer, et al.
Publicado: (2007)

Outbreak report: a nosocomial outbreak of vancomycin resistant enterococci in a solid organ transplant unit
por: Kreidl, Peter, et al.
Publicado: (2018)

Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin
por: Shlezinger, Mor, et al.
Publicado: (2019)

Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing
por: Özsoy, Sevim, et al.
Publicado: (2017)

Excretion of Vancomycin-Resistant Enterococci by Wild Mammals
por: Mallon, David J. P., et al.
Publicado: (2002)

Sink Drains in a Neonatal Intensive Care Unit: A Retrospective Risk Assessment and Evaluation
por: Schneider, Julia S., et al.
Publicado: (2023)

Impact of the coronavirus disease 2019 (COVID-19) pandemic on nosocomial Clostridioides difficile infection
por: Ponce-Alonso, Manuel, et al.
Publicado: (2020)

P067: Economic burden of methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant enterococci in hospitals
por: Mitchell, A, et al.
Publicado: (2013)

Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection
por: Kristen, Zeitler, et al.
Publicado: (2023)

Fecal colonization with vancomycin-resistant enterococci in Australia.
por: Padiglione, A A, et al.
Publicado: (2000)

Involving ornithologists in the surveillance of vancomycin-resistant enterococci.
por: Sellin, M, et al.
Publicado: (2000)

Experience report on surveillance of vancomycin-resistant enterococci
por: Baraldi, MM, et al.
Publicado: (2011)

Genotyping of Vancomycin Resistant Enterococci in Arak Hospitals
por: Hoseini Zadeh, Adeleh, et al.
Publicado: (2015)

Alternatives to Fight Vancomycin-Resistant Staphylococci and Enterococci
por: Baëtz, Benjamin, et al.
Publicado: (2021)

1955. Novel Compound Reverses Vancomycin Resistance in Vancomycin-resistant Enterococci (VRE)
por: Onyedibe, Kenneth, et al.
Publicado: (2019)

Molecular Characterization of Virulence Genes in Vancomycin-Resistant and Vancomycin-Sensitive Enterococci
por: Biswas, Priyanka Paul, et al.
Publicado: (2016)

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
por: Mühlberg, Eric, et al.
Publicado: (2020)

Vancomycin-resistant enterococci outbreak in an intensive care unit: prevention and control
por: Almeida, FP, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_hd78rr7e0k9dnqrob6edcpvnja